期刊文献+

枢复宁在肺癌患者体内的药物动力学和生物利用度 被引量:5

The pharmacokinetic and bioavailability study of ondansetron on primary carcinoma of the lungs
暂未订购
导出
摘要 9名接受顺铂化疗的原发性肺癌患者单次口服和静脉注射枢复宁8mg后,用反相高效液相色谱法测定血浆药物浓度。经用PKBP-N1程序在计算机上拟合计算表明,枢复宁在人体内表现为二房室模型。口服后主要药动学参数:T1/2Ka=0.41±0.30h,T1/2α=0.9±0.43h,T1/2β=3.3±1.2h,Cmax=28.6±9.5ng/ml,Tmax=1.7±0.9h,AUC=158±73ng·h/ml,绝对生物利用度为55%。 he concentration of ondansetron in plasma was determined by reversed phase high performance liquid chromatography.The pharmacokinetics of ondansetron were studied in 9 primary carcinoma of the lungs.After oral and injection administration 8mg,the data obtained were fitted with PKBP N1 program on computer. The results showed that the disposion of ondansetrom was conformed,to a two compartment model with T 1/2 Ka = 0.41 ± 0.3 h, T 1/2 α = 0.9 ± 0.4 h, T 1/2 β = 3.3 ± 1.2 h, C max = 28.6 ± 9.5 ng/ml, T max = 1.7 ± 0.9 h, AUC =158±73(ng·h)/ml,and was absorbed rapidly,distributed widely in the body and also eliminated at a fairly rapid rate.
机构地区 济南军区总医院
出处 《中国医院药学杂志》 CAS CSCD 北大核心 1996年第8期341-343,共3页 Chinese Journal of Hospital Pharmacy
关键词 枢复宁 药物动力学 生物利用度 肺肿瘤 止吐 ondansetron,pharmacokinetics,bioavailability,high performance liquid chromatography
  • 相关文献

同被引文献18

  • 1袁成,张黎明,王景祥,李立君.假尿嘧啶核苷的高效液相色谱法测定及其与原发性肝癌的关系[J].肿瘤,1994,14(4):197-199. 被引量:4
  • 2谢林,刘晓东,郭旭,刘国卿.高效液相色谱法测定人血浆中翁丹西隆浓度[J].中国药科大学学报,1995,26(1):30-32. 被引量:1
  • 3张敏,张乐之,吕金胜,王国华.国产恩丹西酮片药代动力学及生物利用度的研究[J].中国药学杂志,1995,30(11):673-675. 被引量:6
  • 4Cunningham D, Hawthorn J, Pople A, et al. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist[J].Lancet, 1987, 1(8548):1461-1463.
  • 5Colthup PV, Felgate CC, Palmer JL, et al. Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly[J]. J Pharm Sci,1991, 800(9),868-871.
  • 6Spahr-Schopfer IA, Lerman J, Sikich N, et al. Pharmacokinetics of intravenous ondansetron in healthy children undergoing ear, nose, and throat surgery[J].Clin Pharmacol Ther, 1995, 58(3) : 316-321.
  • 7Depot M, Leroux S, Caille G. High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasm[J].J Chromatogr B, 1997, 693(2):399-406.
  • 8Cubeddu LX,Hoffmann IS,Fuenayor NT,et al, Efficacy of ondansetron,and the role of serotonin in cisplatin-induced nausea andvomiting, N Engl J Med,1990,322(12):810.
  • 9Coithup PV, Felgate CC, Jonathan L, et al, Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly J Pharm Sei, 1991,80(9):888.
  • 10Cuaningham D,Turner A,Hawthorn J .et al. Ondansetron with and without dexamethasone to treat chemotherapy-induced emesis. Lancet,1989,1(8650):1323.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部